From: Pulmonary adenoid cystic carcinoma: molecular characteristics and literature review
Ref. | IHC result(No.of patients) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
CK7 | CD117 | P63 | SMA | CK5/6 | S-100 | TTF-1 | CK20 | CgA | CD56 | Napsin A | |
[3] | NM | 9/12 | 12/12 | NM | NM | NM | 4/12 | NM | NM | NM | NM |
[9] | 11/11 | NM | 11/12 | 6/9 | 1/1 | 7/8 | 0/14 | 0/4 | 0/4 | 0/7 | NM |
[10] | 1/1 | 2/2 | 0/2 | NM | 1/2 | NM | 0/2 | NM | NM | 0/1 | NM |
[11] | NM | 20/20 | 20/20 | 20/20 | NM | NM | 0/20 | NM | NM | NM | NM |
[17] | 1/1 | 1/1 | 0/1 | NM | 1/1 | 0/1 | 0/1 | NM | NM | 0/1 | 0/1 |
[29] | NM | 33/34 | NM | NM | NM | NM | NM | NM | NM | NM | NM |
[30] | 1/1 | 1/1 | 1/1 | 1/1 | 1/1 | 1/1 | 0/1 | NM | NM | NM | NM |
[31] | NM | NM | 1/1 | NM | 1/1 | NM | 0/1 | NM | 0/1 | 0/1 | 0/1 |
[32] | 1/1 | 1/1 | 1/1 | NM | NM | NM | NM | NM | NM | NM | NM |
Total | 15/15 | 67/71 | 46/50 | 27/30 | 5/6 | 8/10 | 4/51 | 0/4 | 0/5 | 0/10 | 0/2 |
Rate | 100% | 94.4% | 92.0% | 90.0% | 83.3% | 80% | 7.8% | 0 | 0 | 0 | 0 |